B Group Inc’s Palisade Bio PALI Stock Holding History

B Group Inc’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.9M	Hold	11,414,285	–	–	11.2%	3
2026 Q1	$20M	Buy	11,414,285 +6,914,285	+154%	+$12.6M	14.81%	2
2025 Q4	$10.6M	Buy	+4,500,000	New	+$8.65M	7.81%	3

Other funds holding PALI

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

B Group Inc's PALI Position: Q2 2026 in Review

B Group Inc held its Palisade Bio (PALI) position steady in Q2 2026 at 11,414,285 shares worth $23.9M. The position accounts for 11.2% of the portfolio, ranked #3.

B Group Inc first reported a position in PALI in Q4 2025 and has held it in 3 quarters since. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

B Group Inc held 11,414,285 shares of Palisade Bio worth $23.9M as of Q2 2026.
B Group Inc left its Palisade Bio share count unchanged in Q2 2026.
Palisade Bio made up 11.2% of B Group Inc's portfolio in Q2 2026, its #3 holding.
B Group Inc first reported a position in Palisade Bio in Q4 2025 and has held it in 3 quarters since.
124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on B Group Inc's 13F filing for Q2 2026, filed 14 Aug 2026.